3 Amendments of Christa KLASS related to 2011/0401(COD)
Amendment 250 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 4
Annex I – part III – point 1.1 – paragraph 4
In the Union, CVD annually accounts for more than 2 million deaths and costs the economy more than EUR 192 billion while cancer accounts for a quarter of all deaths and is the number one cause of death in people aged 45-64. Over 27 million people in the Union suffer from diabetes and the total cost of brain disorders (including, but not limited to those affecting mental health) has been estimated at EUR 800 billion. Environmental, life-style and socio-economic factors are relevant in several of these conditions with up to one third of the global disease burden estimated to be related to these. However, for other conditions- in particular neurodegenerative diseases - effective prevention strategies will first require a considerable boost in research into their causes and the development of better early diagnosis and treatment options.
Amendment 285 #
Proposal for a regulation
Annex I – part III – point 1.3 – paragraph 3
Annex I – part III – point 1.3 – paragraph 3
An increasing disease and disability burden in the context of an aging population places further demands on health and care sectors. If effective health and care is to be maintained for all ages, efforts are required to improve decision making in prevention and treatment provision, to identify and support the dissemination of best practice in the health and care sectors, and to support integrated care and the wide uptake of technological, organisational and social innovations empowering in particular older persons, persons with chronic diseases as well as disabled persons to remain active and independent. Doing so will contribute to increasing, and lengthening the duration of their physical, social, and mental well- being.
Amendment 289 #
Proposal for a regulation
Annex I – part III – point 1.3 – paragraph 4
Annex I – part III – point 1.3 – paragraph 4
All of these activities shall be undertaken in such a way as to provide support throughout the research and innovation cycle, strengthening the competitiveness of the European based industries and development of new market opportunities. To this end, a broad basis of research is of utmost importance for a high level of competitivity and future innovation in the European Union;